Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.

0 avis

Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.

Archive ouverte

Edité par CCSD ; LIPPINCOTT WILLIAMS and WILKINS -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Safety and quality of life analyses of apalutamide plus active surveillance vs active surveillance alone for low, intermediate risk prostate cancer.

Archive ouverte | Gravis, Gwenaelle | CCSD

International audience

Feasibility and first results of digital patient-reported outcomes measures (PROMs) data collection for patients with localized prostate cancer at diagnosis.

Archive ouverte | Pignot, Geraldine | CCSD

International audience. 12071 Background: Patient-reported outcomes measures (PROMs) allow optimal evaluation of side effects of treatments and their impact on quality of life. In localized prostate cancer, these PR...

Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review

Archive ouverte | Rony, Maelle | CCSD

International audience. Introduction: Digestive metastases (DMs) from renal cell cancer (RCC) are rare. Over the past decade, the overall survival of metastatic RCC (mRCC) has been improved by tyrosine kinase inhibi...

Chargement des enrichissements...